Imugene (IMU) Price & Analysis

Compare

136 Followers

IMU Stock Chart & Stats

AU$0.32

>-AU$0.01(-2.22%)

At close: Jan 09 4:00 PM EST

AU$0.32

>-AU$0.01(-2.22%)

Day’s Range― - ―

52-Week RangeAU$0.25 - AU$1.60

Previous CloseN/A

Volume11.90M

Average Volume (3M)946.83K

Market Cap

AU$99.33M

Enterprise ValueAU$85.79M

Total Cash (Recent Filing)AU$21.94M

Total Debt (Recent Filing)AU$10.65M

Price to Earnings (P/E)―

Beta1.55

Next Earnings

Mar 04, 2026

EPS Estimate

-0.34

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.09

Shares Outstanding315,326,780

10 Day Avg. Volume810,600

30 Day Avg. Volume946,825

Financial Highlights & Ratios

PEG Ratio0.03

Price to Book (P/B)2.15

Price to Sales (P/S)21.99

P/FCF Ratio-1.07

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$0.82

Price Target Upside154.87% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)-0.68

Revenue Forecast (FY)AU$87.57M

Imugene News

Imugene Enhances Financial Flexibility with Convertible Notes and Warrants Agreement

Imugene ( ($AU:IMU) ) has provided an update. Imugene Limited announced amendments to its existing convertible notes and...

7h ago

Imugene Advances Azer-cel Program with FDA Support and Strategic Partnerships

Imugene ( ($AU:IMU) ) has issued an update. Imugene Limited has announced significant progress in its azer-cel program,...

2d ago

Imugene Announces Webinar on Positive FDA Feedback for Azer-cel Program

The latest update is out from Imugene ( ($AU:IMU) ). Imugene Limited announced a webinar to discuss positive...

11d ago

Imugene Receives FDA Support for Phase 3 Study of Azer-cel

Imugene ( ($AU:IMU) ) has issued an announcement. Imugene Limited has received support from the FDA to advance...

11d ago

Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial

Imugene ( ($AU:IMU) ) just unveiled an update. Imugene Limited has announced promising results from its Phase 1b...

17d ago

Imugene Collaborates with JW Therapeutics on Innovative Cancer Treatment

Imugene ( ($AU:IMU) ) just unveiled an announcement. Imugene Limited announced a strategic collaboration with JW Therapeutics to...

22d ago

Imugene and JW Therapeutics Collaborate on Novel Cancer Therapy

The latest update is out from Imugene ( ($AU:IMU) ). Imugene Ltd and JW Therapeutics have announced a...

22d ago

Imugene AGM Results: Shareholder Dissent and Board Support

Imugene ( ($AU:IMU) ) has provided an announcement. Imugene Limited announced the results of its Annual General Meeting,...

1M ago

Imugene Issues Disclaimer for Annual General Meeting Presentation

An update from Imugene ( ($AU:IMU) ) is now available. Imugene Limited has released a disclaimer regarding its...

1M ago

Imugene Announces Webinar on CAR T Naïve Lymphomas and ASH Presentation

The latest announcement is out from Imugene ( ($AU:IMU) ). Imugene Limited announced an upcoming webinar to discuss...

1M ago

IMU FAQ

What was Imugene’s price range in the past 12 months?

Imugene lowest share price was AU$0.24 and its highest was AU$1.60 in the past 12 months.

What is Imugene’s market cap?

Imugene’s market cap is AU$99.33M.

When is Imugene’s upcoming earnings report date?

Imugene’s upcoming earnings report date is Mar 04, 2026 which is in 76 days.

How were Imugene’s earnings last quarter?

Imugene released its earnings results on Aug 27, 2025. The company reported -AU$0.094 earnings per share for the quarter, beating the consensus estimate of -AU$0.34 by AU$0.246.

Is Imugene overvalued?

According to Wall Street analysts Imugene’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Imugene pay dividends?

Imugene does not currently pay dividends.

What is Imugene’s EPS estimate?

Imugene’s EPS estimate is -0.34.

How many shares outstanding does Imugene have?

Imugene has 315,326,780 shares outstanding.

What happened to Imugene’s price movement after its last earnings report?

Imugene reported an EPS of -AU$0.094 in its last earnings report, beating expectations of -AU$0.34. Following the earnings report the stock price went up 3.846%.

Which hedge fund is a major shareholder of Imugene?

Currently, no hedge funds are holding shares in AU:IMU

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Imugene Stock Smart Score

Neutral

Fundamentals

Return on Equity

-83.09%

Trailing 12-Months

Asset Growth

-45.82%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Imugene

Imugene Limited (ASX: IMU) is a biotechnology company focused on the development of immunotherapies for the treatment of cancer. The company operates in the biopharmaceutical sector, primarily targeting the development of innovative cancer treatments that harness the body’s immune system to fight tumors. Imugene’s core products include oncolytic virotherapy and other immunotherapy candidates designed to enhance the immune response against cancer cells.

Imugene (IMU) Earnings & Revenues

Historic Earnings Reports

IMU Stock 12 Month Forecast

Average Price Target

AU$0.82

▲(154.87% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"AU$18","-1":"-AU$1","3.75":"AU$3.75","8.5":"AU$8.5","13.25":"AU$13.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.821300420325392,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$0.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.8155929312,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$0.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.821300420325392,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$0.82</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,3.75,8.5,13.25,18],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2022","6":"Apr<br/>2024","9":"Jun<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.365,0.40010003233272246,0.4352000646654449,0.4703000969981673,0.5054001293308898,0.5405001616636123,0.5756001939963347,0.6107002263290572,0.6458002586617797,0.6809002909945021,0.7160003233272245,0.751100355659947,0.7862003879926694,{"y":0.821300420325392,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.365,0.3996609947076923,0.4343219894153846,0.46898298412307693,0.5036439788307692,0.5383049735384615,0.5729659682461539,0.6076269629538462,0.6422879576615385,0.6769489523692307,0.711609947076923,0.7462709417846154,0.7809319364923077,{"y":0.8155929312,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.365,0.40010003233272246,0.4352000646654449,0.4703000969981673,0.5054001293308898,0.5405001616636123,0.5756001939963347,0.6107002263290572,0.6458002586617797,0.6809002909945021,0.7160003233272245,0.751100355659947,0.7862003879926694,{"y":0.821300420325392,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.17,"date":1638316800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.6,"date":1640995200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.6,"date":1640995200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.009,"date":1646092800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.12,"date":1654041600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.46,"date":1669852800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.74,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.312,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.054,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.51,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.476,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.3,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.365,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >